| CONTRACT-MANUFACTURING-ORGANIZATIONS |
CONTRACT-MANUFACTURING-ORGANIZATIONS |
92%
|
We do not control the operational processes of the contract manufacturing organizations with whom we contract, and we are dependent on these third parties to produce our product candidates in accorda… |
| THIRD-PARTY-CONTRACT-MANUFACTURERS |
THIRD-PARTY-CONTRACT-MANUFACTURERS |
92%
|
We currently rely on a limited number of third-party contract manufacturers for all the required raw materials for our preclinical research and clinical trials, as well as for the manufacture of our … |
| ACADEMIC-INSTITUTIONS |
ACADEMIC-INSTITUTIONS |
90%
|
We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| CLINICS |
CLINICS |
90%
|
We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| CROS |
CROS |
90%
|
We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| HOSPITALS |
HOSPITALS |
90%
|
We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| OTHER-THIRD-PARTY-STRATEGIC-PARTNERS |
OTHER-THIRD-PARTY-STRATEGIC-PARTNERS |
90%
|
We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
